- Medical Biology - Research Publications
Medical Biology - Research Publications
Permanent URI for this collection
4 results
Filters
Reset filtersSettings
Statistics
Citations
Search Results
Now showing
1 - 4 of 4
-
ItemTransplantable programmed death ligand 1 expressing gastroids from gastric cancer prone Nfkb1-/- miceLow, JT ; Ho, G-Y ; Scott, M ; Tan, CW ; Whitehead, L ; Barber, K ; Yip, HYK ; Dekkers, JF ; Hirokawa, Y ; Silke, J ; Burgess, AW ; Strasser, A ; Putoczki, TL ; O'Reilly, LA (SPRINGERNATURE, 2021-11-17)
-
ItemLoss of NF-kB1 and c-Rel accelerates oral carcinogenesis in miceNi, Y ; Yap, T ; Silke, N ; Silke, J ; McCullough, M ; Celentano, A ; O'Reilly, LA (WILEY, 2021-03)
-
ItemNo Preview AvailableMCL-1 is essential for survival but dispensable for metabolic fitness of FOXP3+regulatory T cellsTeh, CE ; Robbins, AK ; Henstridge, DC ; Dewson, G ; Diepstraten, ST ; Kelly, G ; Febbraio, MA ; Gabriel, SS ; O'Reilly, LA ; Strasser, A ; Gray, DHD (SPRINGERNATURE, 2020-12)FOXP3+ regulatory T (Treg) cells are essential for maintaining immunological tolerance. Given their importance in immune-related diseases, cancer and obesity, there is increasing interest in targeting the Treg cell compartment therapeutically. New pharmacological inhibitors that specifically target the prosurvival protein MCL-1 may provide this opportunity, as Treg cells are particularly reliant upon this protein. However, there are two distinct isoforms of MCL-1; one located at the outer mitochondrial membrane (OMM) that is required to antagonize apoptosis, and another at the inner mitochondrial membrane (IMM) that is reported to maintain IMM structure and metabolism via ATP production during oxidative phosphorylation. We set out to elucidate the relative importance of these distinct biological functions of MCL-1 in Treg cells to assess whether MCL-1 inhibition might impact upon the metabolism of cells able to resist apoptosis. Conditional deletion of Mcl1 in FOXP3+ Treg cells resulted in a lethal multiorgan autoimmunity due to the depletion of the Treg cell compartment. This striking phenotype was completely rescued by concomitant deletion of the apoptotic effector proteins BAK and BAX, indicating that apoptosis plays a pivotal role in the homeostasis of Treg cells. Notably, MCL-1-deficient Treg cells rescued from apoptosis displayed normal metabolic capacity. Moreover, pharmacological inhibition of MCL-1 in Treg cells resistant to apoptosis did not perturb their metabolic function. We conclude that Treg cells require MCL-1 only to antagonize apoptosis and not for metabolism. Therefore, MCL-1 inhibition could be used to manipulate Treg cell survival for clinical benefit without affecting the metabolic fitness of cells resisting apoptosis.
-
ItemNo Preview AvailablePtpn6 inhibits caspase-8-and Ripk3/Mlkl-dependent inflammationSpeir, M ; Nowell, CJ ; Chen, AA ; O'Donnell, JA ; Shamie, IS ; Lakin, PR ; D'Cruz, AA ; Braun, RO ; Babon, JJ ; Lewis, RS ; Bliss-Moreau, M ; Shlomovitz, I ; Wang, S ; Cengia, LH ; Stoica, AI ; Hakem, R ; Kelliher, MA ; O'Reilly, LA ; Patsiouras, H ; Lawlor, KE ; Weller, E ; Lewis, NE ; Roberts, AW ; Gerlic, M ; Croker, BA (NATURE PORTFOLIO, 2020-01)Ptpn6 is a cytoplasmic phosphatase that functions to prevent autoimmune and interleukin-1 (IL-1) receptor-dependent, caspase-1-independent inflammatory disease. Conditional deletion of Ptpn6 in neutrophils (Ptpn6∆PMN) is sufficient to initiate IL-1 receptor-dependent cutaneous inflammatory disease, but the source of IL-1 and the mechanisms behind IL-1 release remain unclear. Here, we investigate the mechanisms controlling IL-1α/β release from neutrophils by inhibiting caspase-8-dependent apoptosis and Ripk1-Ripk3-Mlkl-regulated necroptosis. Loss of Ripk1 accelerated disease onset, whereas combined deletion of caspase-8 and either Ripk3 or Mlkl strongly protected Ptpn6∆PMN mice. Ptpn6∆PMN neutrophils displayed increased p38 mitogen-activated protein kinase-dependent Ripk1-independent IL-1 and tumor necrosis factor production, and were prone to cell death. Together, these data emphasize dual functions for Ptpn6 in the negative regulation of p38 mitogen-activated protein kinase activation to control tumor necrosis factor and IL-1α/β expression, and in maintaining Ripk1 function to prevent caspase-8- and Ripk3-Mlkl-dependent cell death and concomitant IL-1α/β release.